Skin Cancer News & Features
Link with overall, melanoma-specific survival; increase in CRP also linked to disease progression
Treating metastatic melanoma with a combination of radiotherapy and two immunotherapies that target the CTLA4 and PD-1 pathways could produce an optimal response in more patients.
A new way may have been discovered to more accurately predict the patients likely to respond to genomic-based follow-up therapies, by looking at unique protein patterns in patients with melanoma.
Melanoma in some adolescent and adult patients involve many of the same genetic mutations and would likely respond to the same treatment.
Melanoma screening strategies may be more feasible by focusing on high-risk populations.
- Angelina Jolie has ovaries, fallopian tubes removed over cancer concerns
- Counseling cancer patients on effective nutritional practices
- Radiation plus immunotherapy revs up immune system to better attack melanoma
- Algorithm increases surgical success in advanced ovarian cancer
- Chemotherapy before breast cancer surgery increases likelihood of breast-preserving procedure
- Chromosomal rearrangement is key to progress against aggressive infant leukemia
- Risk of thyroid cancer increases after a breast cancer diagnosis
- Vaccine may delay recurrence for advanced ovarian cancers
- High fish intake may improve survival after breast cancer
- Adding bevacizumab to standard chemotherapy improves overall survival for women with ovarian cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|